Clinical trial
A Comparison Study With Alendronate and Raloxifene in Postmenopausal Women With…
NCT00389740 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00389740 |
|---|---|
| Title | A Comparison Study With Alendronate and Raloxifene in Postmenopausal Women With Osteoporosis (0217-189) |
| Official title | A Randomized, Double-Blind, Double-Dummy, Parallel-Group, Multicenter Study to Evaluate and Compare the Effects of Alendronate and Raloxifene on Bone Mineral Density in Postmenopausal Women With Osteoporosis |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoporosis, Postmenopausal |
| Intervention type | Drug |
| Interventions | MK0217, /Duration of Treatment : 12 Months, Comparator : raloxifene hydrochloride /Duration of Treatment : 12 Months |
| Enrollment | 400 |
| Start date | Apr 2, 2001 |
| Primary completion | Jan 16, 2003 |
| Completion | Jan 16, 2003 |
| First posted | Oct 19, 2006 |
| Last update posted | Aug 14, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: